GlassScriptPhysician profile
Sushma Bhadauria
NPI 1164472460
$1,298.18
in general payments reported to CMS, 2019-2025
17 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $167 · 2021: $203 · 2022: $53.32 · 2023: $104 · 2024: $411 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $641.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $422.74 | 2023-2024 | Dovato |
| Abbvie INC. | $175.71 | 2020-2022 | |
| Allergan, INC. | $110.96 | 2019-2020 | |
| Lupin INC. | $100.97 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $100.44 | 2019-2021 | |
| Hologic Sales and Service, LLC | $75.10 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $70.07 | 2019-2024 | Slynd |
| Sage Therapeutics, LLC | $40.48 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $39.45 | 2021-2023 | Phexxi |
| Mayne Pharma Commercial LLC | $29.50 | 2022 | |
| Lilly USA, LLC | $25.41 | 2025 | Mounjaro, Zepbound |
| Duchesnay USA Incorporated | $21.91 | 2019 | |
| Sumitomo Pharma America, INC. | $21.10 | 2023 | Myfembree |
| Coopersurgical, INC. | $19.49 | 2021 | |
| Currax Pharmaceuticals LLC | $17.81 | 2025 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.11 | 2025 | Qelbree |
| Therapeuticsmd, INC. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushma Bhadauria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.